NO20034715L - Krystallinsk form av omeprazol - Google Patents

Krystallinsk form av omeprazol

Info

Publication number
NO20034715L
NO20034715L NO20034715A NO20034715A NO20034715L NO 20034715 L NO20034715 L NO 20034715L NO 20034715 A NO20034715 A NO 20034715A NO 20034715 A NO20034715 A NO 20034715A NO 20034715 L NO20034715 L NO 20034715L
Authority
NO
Norway
Prior art keywords
omeprazole
crystalline form
methoxy
disclosed
sulfiny
Prior art date
Application number
NO20034715A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034715D0 (no
Inventor
Milae Natasa Hafner
Anton Eopar
Barbara Podobnik
Beleie Andreja Cizerle
Alenka Kosak
Brina Ornik
Uros Urleb
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034715(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of NO20034715D0 publication Critical patent/NO20034715D0/no
Publication of NO20034715L publication Critical patent/NO20034715L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20034715A 2001-04-25 2003-10-21 Krystallinsk form av omeprazol NO20034715L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200100111A SI20875A (sl) 2001-04-25 2001-04-25 Kristalna oblika omeprazola
PCT/IB2002/001350 WO2002085889A1 (en) 2001-04-25 2002-04-24 Crystalline form of omeprazole

Publications (2)

Publication Number Publication Date
NO20034715D0 NO20034715D0 (no) 2003-10-21
NO20034715L true NO20034715L (no) 2003-12-10

Family

ID=20432882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034715A NO20034715L (no) 2001-04-25 2003-10-21 Krystallinsk form av omeprazol

Country Status (26)

Country Link
US (2) US20040122056A1 (sl)
EP (1) EP1390360B1 (sl)
JP (1) JP4455815B2 (sl)
KR (1) KR20030094358A (sl)
CN (1) CN1531533B (sl)
AT (1) ATE346063T1 (sl)
AU (1) AU2002307892B2 (sl)
BG (1) BG108287A (sl)
BR (1) BR0209103A (sl)
CA (1) CA2445251C (sl)
CZ (1) CZ20032911A3 (sl)
DE (1) DE60216273T2 (sl)
HR (1) HRP20030853B1 (sl)
HU (1) HUP0303928A2 (sl)
IL (1) IL158561A0 (sl)
MX (1) MXPA03009789A (sl)
NO (1) NO20034715L (sl)
NZ (1) NZ528917A (sl)
PL (1) PL366471A1 (sl)
RS (1) RS50880B (sl)
RU (1) RU2286991C2 (sl)
SI (2) SI20875A (sl)
SK (1) SK13192003A3 (sl)
UA (1) UA77671C2 (sl)
WO (1) WO2002085889A1 (sl)
ZA (1) ZA200307988B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1904064A4 (en) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr OMEPRAZOLE OF FORM B
PL1988163T3 (pl) * 2006-02-22 2012-11-30 Int Inst Cancer Immunology Inc Ograniczony do hla-a*3303 peptyd wt1 i zawierająca go kompozycja farmaceutyczna
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
EP2114919A2 (en) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN102786513A (zh) * 2011-05-18 2012-11-21 中国医学科学院药物研究所 奥美拉唑晶e型物质及制备方法与在药品和保健品中应用
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
KR101459088B1 (ko) * 2012-08-02 2014-12-02 대화제약 주식회사 알-라베프라졸, 이의 금속염의 제조방법
EP4426694A1 (en) * 2021-11-05 2024-09-11 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
ES2078447T3 (es) * 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
AUPQ841800A0 (en) * 2000-06-28 2000-07-20 Biomolecular Research Institute Limited Truncated egf receptor
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
YU84003A (sh) 2006-08-17
EP1390360B1 (en) 2006-11-22
ATE346063T1 (de) 2006-12-15
RU2003133213A (ru) 2005-05-10
UA77671C2 (en) 2007-01-15
SI1390360T1 (sl) 2007-04-30
JP4455815B2 (ja) 2010-04-21
US7553856B2 (en) 2009-06-30
NZ528917A (en) 2006-02-24
EP1390360A1 (en) 2004-02-25
HRP20030853A2 (en) 2005-08-31
PL366471A1 (en) 2005-02-07
MXPA03009789A (es) 2005-03-07
US20040122056A1 (en) 2004-06-24
CA2445251A1 (en) 2002-10-31
DE60216273T2 (de) 2007-05-31
HRP20030853B1 (en) 2011-11-30
CN1531533B (zh) 2012-07-18
JP2004526786A (ja) 2004-09-02
BG108287A (bg) 2005-04-30
RS50880B (sr) 2010-08-31
CN1531533A (zh) 2004-09-22
NO20034715D0 (no) 2003-10-21
US20060079560A1 (en) 2006-04-13
CZ20032911A3 (en) 2004-06-16
RU2286991C2 (ru) 2006-11-10
WO2002085889A1 (en) 2002-10-31
DE60216273D1 (de) 2007-01-04
AU2002307892B2 (en) 2008-04-17
IL158561A0 (en) 2004-05-12
HUP0303928A2 (hu) 2004-03-01
SI20875A (sl) 2002-10-31
KR20030094358A (ko) 2003-12-11
ZA200307988B (en) 2004-10-14
SK13192003A3 (sk) 2004-03-02
BR0209103A (pt) 2004-07-13
CA2445251C (en) 2011-01-04

Similar Documents

Publication Publication Date Title
NO20034715D0 (no) Krystallinsk form av omeprazol
TR200101282T2 (tr) Omeprozolün yeni kristalli formu
AR010361A1 (es) "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS"
MY127871A (en) Omeprazole sodium salt
CA2357744A1 (en) Potassium salt of (s)-omeprazole
WO1998054171A8 (en) Novel form of s-omeprazole
MY111737A (en) Use of omeprazole as an antimicrobial agent.
CL2009000805A1 (es) Composicion farmaceutica que comprende a una sal sodica del enantiomero (-) de 5-metoxi-2[[(4-metoxi-3,5-dimetil-2-piridinil)metil]sulfinil]-1h-bencimidazol ((-)-omeprazol); y su uso en la inhibicion de la secrecion de acido gastrico y para tratar enfermedades inflamatorias gastrointestinales. (divisional solicitud 3570-00).
JP2002535401A5 (sl)
AR013740A1 (es) Proceso para la preparacion de omeprazol, compuesto y formulacion farmaceutica del mismo
ATE363480T1 (de) Alkylammoniumsalze von omeprazol und esomeprazol
SE0302382D0 (sv) New salts II
JP2007504223A5 (sl)
JP2007504222A5 (sl)
YU32301A (sh) Novi kristalni oblik omeprazola
MY118724A (en) New crystalline form of omeprazole
US20050131026A1 (en) Use of proton pump inhibitors for the treatment of airway disorders
JP2005523298A (ja) 非心臓性胸痛の治療のためのプロトンポンプ阻害剤の使用

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application